US › Healthcare

Onconetix Inc (ONCO)

US · Healthcare · Biotechnology

$0.550.00%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$17,120

Revenue YoY

-83.9%

Net profit

$-2.9M

EPS

$-1.28

Net margin

-16,748.3%

Key statistics

Market cap

$323,183

P/E

0.0

Forward P/E

0.0

P/B

0.24

Book value

$35.50

EPS (TTM)

$3,103.90

52-week high

$1,610.00

52-week low

$3.42

50-day MA

$6.62

200-day MA

$102.53

Beta

2.62

Analyst view

with an average price target of $9.00.

Shareholding

Insiders

0.11%

Institutions

5.18%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	0.98%
XTX Topco Ltd	0.26%
SBI Securities Co Ltd	0.00%
Tower Research Capital LLC	0.00%
Hollencrest Securities, LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Geode Capital Management, LLC	0.00%
Citigroup Inc	0.00%

Corporate actions

Action	Detail	Date
Split	1 : 10 effective Nov 6, 2026	2026-11-06

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Onconetix Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.